• Home
  • Margetuximab in HER2-positive metastatic breast cancer.

Margetuximab in HER2-positive metastatic breast cancer.

Author List
Gradishar WJ, O'Regan R, Rimawi MF, Nordstrom JL, Rosales MK, Rugo HS
Publication
Future oncology (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/396767497
Publication Year
2023
PubMed ID
37170847
Publication Title
Gradishar WJ, O'Regan R, Rimawi MF, Nordstrom JL, Rosales MK, Rugo HS. Margetuximab in HER2-positive metastatic breast cancer. Future Oncol. 2023 May; 19(16):1099-1112.